Spontaneous and stimulated interleukin-6 and tumor necrosis factor-alpha production at delivery and three months after birth

European Cytokine Network

Volumn 15, Issue 1, 2004, Pages 67-72

  Keski Nisula, Leea ^a,b,c   Hirvonen, Maija Riitta ^a   Roponen, Marjut ^a   Heinonen, Seppo ^b   Pekkanen, Juha ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NONE   (Finland)

Author keywords

Birth; Delivery; IL 6; Neonate; TNF alpha

Indexed keywords

CONCANAVALIN A; INTERLEUKIN 6; PHORBOL 12 ACETATE 13 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD CULTURE; CHILDBIRTH; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS BLOOD SAMPLING; HUMAN; HUMAN CELL; INFANT; LABOR; MATERNAL AGE; MATERNAL BLOOD; NEWBORN; NORMAL HUMAN; PERIPHERAL VEIN; PROTEIN EXPRESSION; PUERPERIUM; STIMULATION; SUPERNATANT; UMBILICAL CORD BLOOD; VAGINAL DELIVERY;

ADULT; AGE FACTORS; CARCINOGENS; CONCANAVALIN A; DELIVERY, OBSTETRIC; DOWN-REGULATION; FEMALE; FETAL BLOOD; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; POSTPARTUM PERIOD; PREGNANCY; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2342534376     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Chaouat G, Zourbas S, Ostojic S, Lappree-Delage G, Dubanchet S, Ledee N, Martal J. 2002. A brief review of recent data on some cytokine expressions at the materno-foetal interface which might challenge the classical Th1/Th2 dichotomy. J. Reprod. Immunol. 53: 241.
2. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M. 1996. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin. Exp. Immunol. 106: 127.
3. Dealtry GB, O'Farrell MK, Fernandez N. 2000. The Th2 cytokine environment of the placenta. Int Arch Allergy Immunol 123: 107.
4. Saito S. Cytokine network at the feto-maternal interface. 2000. J. Reprod. Immunol. 47: 87.
5. Ho HN, Chao KH, Chen HF, Chen SU, Wu MY, Yang YS. 2001. Distribution of Th1 and Th2 cell populations in human peripheral and decidual T cells from normal and anembryonic pregnancies. Fertil. Steril. 76: 797.
6. Sacks GP, Clover LM, Bainbridge DR, Redman CW, Sargent IL. 2001. Flow cytometric measurement of intracellular Th1 and Th2 cytokine production by human villous and extravillous cytotrophoblast. Placenta 22: 550.
7. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM. 1998. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am. J. Obstet. Gynecol. 179: 186.
8. Zenclussen AC, Fest S, Sehmsdorf US, Hagen E, Klapp BF, Arck PC. 2001. Upregulation of decidual P-selectin expression is associated with an increased number of Th1 cell populations in patients suffering from spontaneous abortions. Cell. Immunol. 213: 94.
9. Wang ZC, Yunis EJ, De Los Santos MJ, Xiao L, Anderson DJ, Hill JA. 2002. T helper 1-type immunity to trophoblast antigens in women with a history of recurrent pregnancy loss is associated with polymorphism of the IL1B promoter region. Genes Immun. 3: 38.
10. Steinborn A, Kuhnert M, Halberstadt E. 1996. Immunomodulating cytokines induce term and preterm parturition. J. Perinat. Med. 24: 381.
11. Opsjon SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R. 1993. Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am. J. Obstet. Gynecol. 169: 397.
12. Greig PC, Murtha AP, Jimmerson CJ, Herbert WN, Roitman-Johnson B, Allen J. 1997. Maternal serum interleukin-6 during pregnancy and during term and preterm labor. Obstet. Gynecol. 90: 465.
13. Arntzen KJ, Lien E, Austgulen R. 1997. Maternal serum levels of interleukin-6 and clinical characteristics of normal delivery at term. Acta. Obstet. Gynecol. Scand. 76: 55.
14. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. 1998. The fetal inflammatory response syndrome. Am. J. Obstet. Gynecol. 179: 194.
15. Duggan PJ, Maalouf EF, Watts TL, Sullivan MH, Counsell SJ, Allsop J, Al-Nakib L, Rutherford MA, Battin M, Roberts I, Edwards AD. 2001. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 358: 1699.
16. Matthiesen L, Ekerfelt C, Berg G, Ernerudh J. 1998. Increased numbers of circulating interferon-gamma- and interleukin-4-secreting cells during normal pregnancy. Am. J. Reprod. Immunol. 39: 362.
17. Veith GL, Rice GE. 1999. Interferon gamma expression during human pregnancy and in association with labour. Gynecol. Obstet. Invest. 48: 163.
18. Ida A, Tsuji Y, Muranaka J, Kanazawa R, Nakata Y, Adachi S, Okamura H, Koyama K. 2000. IL-18 in pregnancy; the elevation of IL-18 in maternal peripheral blood during labour and complicated pregnancies. J. Reprod. Immunol. 47: 65.
19. Shimaoka Y, Hidaka Y, Tada H, Nakamura T, Mitsuda N, Morimoto Y, Murata Y, Amino N. 2000. Changes in cytokine production during and after normal pregnancy. Am. J. Reprod. Immunol. 44: 143.
20. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. 1992. FASEB J 6: 2591.
21. Guilbert L, Robertson SA, Wegmann TG. 1993. The trophoblast as an integral component of a macrophage-cytokine network. Immunol. Cell. Biol. 71: 49.
22. Olah KS, Vince GS, Neilson JP, Deniz G, Johnson PM. 1996. Interleukin-6, interferon-gamma, interleukin-8, and granulocyte-macrophage colony stimulating factor levels in human amniotic fluid at term. J. Reprod. Immunol. 32: 89.
23. Tranchot-Diallo J, Gras G, Parnet-Mathieu F, Benveniste O, Marce D, Roques P, Milliez J, Chaouat G, Dormont D. 1997. Modulations of cytokine expression in pregnant women. Am. J. Reprod. Immunol. 37: 215.
24. Vassiliadis S, Ranella A, Papadimitriou L, Makrygiannakis A, Athanassakis I. 1998. Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion. Mediators Inflamm. 7: 69.
25. Buonocore G, De Filippo M, Gioia D, Picciolini E, Luzzi E, Bocci V, Bracci R. 1995. Maternal and neonatal plasma cytokine levels in relation to mode of delivery. Biol. Neonate. 68: 104.
26. Arntzen KJ, Liabakk NB, Jacobsen G, Espevik T, Austgulen R. 1995. Soluble tumor necrosis factor receptor in serum and urine throughout normal pregnancy and at delivery. Am. J. Reprod. Immunol. 34: 163.
27. Jokic M, Guillois B, Cauquelin B, Giroux JD, Bessis JL, Morello R, Levy G, Ballet JJ. 2000. Fetal distress increases interleukin-6 and interleukin-8 and decreases tumour necrosis factor-alpha cord blood levels in noninfected full-term neonates. Br. J. Obstet. Gynaecol. 107: 420.
28. Elenkov IJ, Wilder RL, Bakalov VK, Link AA, Dimitrov MA, Fisher S, Crane M, Kanik KS, Chrousos GP. 2001. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J. Clin. Endocrinol. Metab. 86: 4933.
29. Seghaye MC, Heyl W, Grabitz RG, Schumacher K, von Bernuth G, Rath W, Duchateau J. 1998. The production of pro- and anti-inflammatory cytokines in neonates assessed by stimulated whole cord blood culture and by plasma levels at birth. Biol. Neonate. 73: 220.
30. Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D, Padbury J, Sharma S. 2000. Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J. Immunol. 164: 5721.